Business development companies (BDCs) are increasingly using off balance sheet investment vehicles called senior secured loan programmes (SSLPs) to increase their effective portfolio leverage without running afoul of regulatory limits on balance sheet leverage. This is a trend that adds incremental risks, according to Fitch Ratings. SSLPs are receiving
One in five (21 per cent) small and medium sized businesses (SMEs) cite cash flow as a major challenge to growth, according to a new study by venture capital investor Albion Ventures. Albion’s research shows that cash flow concerns are far higher among firms that are increasingly confident about the
The stockmarket outperformance of family businesses is being described as the “Family Premium” in a report by leading academics at the IE business school in Madrid. Yet ironically ‘family businesses’ – those quoted companies where an individual or family holds at least 20 per cent of the company’s shares and at
A study by private equity advisory firm Agamya Capital has found a remarkable consistency in investing by sector for the top sectors in pre- as well as post-2009 era of private equity investing. The study looked at current investments of private equity firms in the US, with a primary focus
Over three-fifths of institutional investors have chosen not to invest in a private equity fund as a direct result of unfavourable fund terms, according to a Preqin study. Data from Preqin’s forthcoming 2014 Private Equity Fund Terms Advisor suggests that private equity fund managers are not doing enough to appease
The combined value of offshore deals in the second quarter of 2014 jumped 23 per cent over the previous one, making it one of the highest value quarters of the past decade, according to a report by Appleby. Given that the first half of the year is frequently quieter than the
Regulation is slowing the push for alternative investments, according to research released by Cerulli Associates. "Alternative investments and other non-traditional asset classes are slowly becoming a larger part of the investment landscape," says Pamela DeBolt, associate director at Cerulli. "This acceptance is playing out in several areas: through increased allocations
The European buy and build market has experienced very low activity levels and deal values in quarter one 2014 dragging down half year figures, according to figures released by Silverfleet Capital and Mergermarket. The European Buy & Build Monitor for H1 2014, which tracks add-on activity undertaken by European companies
The gradual economic improvement in Europe, increasingly liquid debt markets and stronger IPO market conditions supported an increase in exit activity of PE-backed businesses in 2013. That’s according to EY’s ninth annual European PE exits study. Last year saw 77 exits in the population covered by the study versus 61
Venture capital (VC) funding for the life sciences sector, which includes biotechnology and medical devices, reached USD2.5 billion in 195 deals for the second quarter of 2014, according to a report. The report, which includes data from the MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA),
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
